United States · FDA National Drug Code directory
Rasagiline
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 83085-007_9ce75c86-75fb-4e5d-a5a6-25696c5593f4
- Product NDC
- 83085-007
- Form
- TABLET
- Composition / generic term
- Rasagiline mesylate
- Labeler
- SKG Pharma Inc.
- Marketing category
- ANDA
- Marketing start / end (source format)
- 20250404
- Source listing expiry
- 20261231
Source-listed ingredients
- RASAGILINE MESYLATE — .5 mg/1
These values do not establish equivalence or a dose recommendation.
Packages
- 1000 TABLET in 1 BOTTLE (83085-007-10) · 83085-007-10
- 30 TABLET in 1 BOTTLE (83085-007-30) · 83085-007-30
- 500 TABLET in 1 BOTTLE (83085-007-50) · 83085-007-50
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →